Oligonucleotides Market - Global Outlook and Forecast 2021-2027

Oligonucleotides Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ775647 | No. of Pages: 100 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jun-2021
This report contains market size and forecasts of Oligonucleotides in Global, including the following market information:
Global Oligonucleotides Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Oligonucleotides market was valued at 1103 million in 2020 and is projected to reach US$ 1595.4 million by 2027, at a CAGR of 9.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oligonucleotides companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oligonucleotides Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Oligonucleotides Market Segment Percentages, By Type, 2020 (%)
    DNA Oligos
    RNA Oligos

China Oligonucleotides Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Oligonucleotides Market Segment Percentages, By Application, 2020 (%)
    Pharmaceutical
    Research
    Diagnostic

Global Oligonucleotides Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Oligonucleotides Market Segment Percentages, By Region and Country, 2020 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Oligonucleotides Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Oligonucleotides Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
    Integrated DNA Technologies
    Agilent
    Sigma-aldrich
    Eurofins Genomics
    L.G.C Biosearch Technologies
    Eurogentec S.A
    Nitto Denko Avecia Inc
    GenScript
    BBI Life Sciences
    GeneDesign
    TriLink BioTechnologies
    SGS DNA
    LC Sciences
    Twist Bioscience
    Creative Biogene
    General Biosystems
1 Introduction to Research & Analysis Reports
    1.1 Oligonucleotides Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oligonucleotides Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oligonucleotides Overall Market Size
    2.1 Global Oligonucleotides Market Size: 2021 VS 2027
    2.2 Global Oligonucleotides Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Oligonucleotides Players in Global Market
    3.2 Top Global Oligonucleotides Companies Ranked by Revenue
    3.3 Global Oligonucleotides Revenue by Companies
    3.4 Top 3 and Top 5 Oligonucleotides Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Oligonucleotides Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Oligonucleotides Players in Global Market
        3.6.1 List of Global Tier 1 Oligonucleotides Companies
        3.6.2 List of Global Tier 2 and Tier 3 Oligonucleotides Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Oligonucleotides Market Size Markets, 2021 & 2027
        4.1.2 DNA Oligos
        4.1.3 RNA Oligos
    4.2 By Type - Global Oligonucleotides Revenue & Forecasts
        4.2.1 By Type - Global Oligonucleotides Revenue, 2016-2021
        4.2.2 By Type - Global Oligonucleotides Revenue, 2022-2027
        4.2.3 By Type - Global Oligonucleotides Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Oligonucleotides Market Size, 2021 & 2027
        5.1.2 Pharmaceutical
        5.1.3 Research
        5.1.4 Diagnostic
    5.2 By Application - Global Oligonucleotides Revenue & Forecasts
        5.2.1 By Application - Global Oligonucleotides Revenue, 2016-2021
        5.2.2 By Application - Global Oligonucleotides Revenue, 2022-2027
        5.2.3 By Application - Global Oligonucleotides Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Oligonucleotides Market Size, 2021 & 2027
    6.2 By Region - Global Oligonucleotides Revenue & Forecasts
        6.2.1 By Region - Global Oligonucleotides Revenue, 2016-2021
        6.2.2 By Region - Global Oligonucleotides Revenue, 2022-2027
        6.2.3 By Region - Global Oligonucleotides Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Oligonucleotides Revenue, 2016-2027
        6.3.2 US Oligonucleotides Market Size, 2016-2027
        6.3.3 Canada Oligonucleotides Market Size, 2016-2027
        6.3.4 Mexico Oligonucleotides Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Oligonucleotides Revenue, 2016-2027
        6.4.2 Germany Oligonucleotides Market Size, 2016-2027
        6.4.3 France Oligonucleotides Market Size, 2016-2027
        6.4.4 U.K. Oligonucleotides Market Size, 2016-2027
        6.4.5 Italy Oligonucleotides Market Size, 2016-2027
        6.4.6 Russia Oligonucleotides Market Size, 2016-2027
        6.4.7 Nordic Countries Oligonucleotides Market Size, 2016-2027
        6.4.8 Benelux Oligonucleotides Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Oligonucleotides Revenue, 2016-2027
        6.5.2 China Oligonucleotides Market Size, 2016-2027
        6.5.3 Japan Oligonucleotides Market Size, 2016-2027
        6.5.4 South Korea Oligonucleotides Market Size, 2016-2027
        6.5.5 Southeast Asia Oligonucleotides Market Size, 2016-2027
        6.5.6 India Oligonucleotides Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Oligonucleotides Revenue, 2016-2027
        6.6.2 Brazil Oligonucleotides Market Size, 2016-2027
        6.6.3 Argentina Oligonucleotides Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Oligonucleotides Revenue, 2016-2027
        6.7.2 Turkey Oligonucleotides Market Size, 2016-2027
        6.7.3 Israel Oligonucleotides Market Size, 2016-2027
        6.7.4 Saudi Arabia Oligonucleotides Market Size, 2016-2027
        6.7.5 UAE Oligonucleotides Market Size, 2016-2027
7 Players Profiles
    7.1 Integrated DNA Technologies
        7.1.1 Integrated DNA Technologies Corporate Summary
        7.1.2 Integrated DNA Technologies Business Overview
        7.1.3 Integrated DNA Technologies Oligonucleotides Major Product Offerings
        7.1.4 Integrated DNA Technologies Oligonucleotides Revenue in Global (2016-2021)
        7.1.5 Integrated DNA Technologies Key News
    7.2 Agilent
        7.2.1 Agilent Corporate Summary
        7.2.2 Agilent Business Overview
        7.2.3 Agilent Oligonucleotides Major Product Offerings
        7.2.4 Agilent Oligonucleotides Revenue in Global (2016-2021)
        7.2.5 Agilent Key News
    7.3 Sigma-aldrich
        7.3.1 Sigma-aldrich Corporate Summary
        7.3.2 Sigma-aldrich Business Overview
        7.3.3 Sigma-aldrich Oligonucleotides Major Product Offerings
        7.3.4 Sigma-aldrich Oligonucleotides Revenue in Global (2016-2021)
        7.3.5 Sigma-aldrich Key News
    7.4 Eurofins Genomics
        7.4.1 Eurofins Genomics Corporate Summary
        7.4.2 Eurofins Genomics Business Overview
        7.4.3 Eurofins Genomics Oligonucleotides Major Product Offerings
        7.4.4 Eurofins Genomics Oligonucleotides Revenue in Global (2016-2021)
        7.4.5 Eurofins Genomics Key News
    7.5 L.G.C Biosearch Technologies
        7.5.1 L.G.C Biosearch Technologies Corporate Summary
        7.5.2 L.G.C Biosearch Technologies Business Overview
        7.5.3 L.G.C Biosearch Technologies Oligonucleotides Major Product Offerings
        7.5.4 L.G.C Biosearch Technologies Oligonucleotides Revenue in Global (2016-2021)
        7.5.5 L.G.C Biosearch Technologies Key News
    7.6 Eurogentec S.A
        7.6.1 Eurogentec S.A Corporate Summary
        7.6.2 Eurogentec S.A Business Overview
        7.6.3 Eurogentec S.A Oligonucleotides Major Product Offerings
        7.6.4 Eurogentec S.A Oligonucleotides Revenue in Global (2016-2021)
        7.6.5 Eurogentec S.A Key News
    7.7 Nitto Denko Avecia Inc
        7.7.1 Nitto Denko Avecia Inc Corporate Summary
        7.7.2 Nitto Denko Avecia Inc Business Overview
        7.7.3 Nitto Denko Avecia Inc Oligonucleotides Major Product Offerings
        7.4.4 Nitto Denko Avecia Inc Oligonucleotides Revenue in Global (2016-2021)
        7.7.5 Nitto Denko Avecia Inc Key News
    7.8 GenScript
        7.8.1 GenScript Corporate Summary
        7.8.2 GenScript Business Overview
        7.8.3 GenScript Oligonucleotides Major Product Offerings
        7.8.4 GenScript Oligonucleotides Revenue in Global (2016-2021)
        7.8.5 GenScript Key News
    7.9 BBI Life Sciences
        7.9.1 BBI Life Sciences Corporate Summary
        7.9.2 BBI Life Sciences Business Overview
        7.9.3 BBI Life Sciences Oligonucleotides Major Product Offerings
        7.9.4 BBI Life Sciences Oligonucleotides Revenue in Global (2016-2021)
        7.9.5 BBI Life Sciences Key News
    7.10 GeneDesign
        7.10.1 GeneDesign Corporate Summary
        7.10.2 GeneDesign Business Overview
        7.10.3 GeneDesign Oligonucleotides Major Product Offerings
        7.10.4 GeneDesign Oligonucleotides Revenue in Global (2016-2021)
        7.10.5 GeneDesign Key News
    7.11 TriLink BioTechnologies
        7.11.1 TriLink BioTechnologies Corporate Summary
        7.11.2 TriLink BioTechnologies Business Overview
        7.11.3 TriLink BioTechnologies Oligonucleotides Major Product Offerings
        7.11.4 TriLink BioTechnologies Oligonucleotides Revenue in Global (2016-2021)
        7.11.5 TriLink BioTechnologies Key News
    7.12 SGS DNA
        7.12.1 SGS DNA Corporate Summary
        7.12.2 SGS DNA Business Overview
        7.12.3 SGS DNA Oligonucleotides Major Product Offerings
        7.12.4 SGS DNA Oligonucleotides Revenue in Global (2016-2021)
        7.12.5 SGS DNA Key News
    7.13 LC Sciences
        7.13.1 LC Sciences Corporate Summary
        7.13.2 LC Sciences Business Overview
        7.13.3 LC Sciences Oligonucleotides Major Product Offerings
        7.13.4 LC Sciences Oligonucleotides Revenue in Global (2016-2021)
        7.13.5 LC Sciences Key News
    7.14 Twist Bioscience
        7.14.1 Twist Bioscience Corporate Summary
        7.14.2 Twist Bioscience Business Overview
        7.14.3 Twist Bioscience Oligonucleotides Major Product Offerings
        7.14.4 Twist Bioscience Oligonucleotides Revenue in Global (2016-2021)
        7.14.5 Twist Bioscience Key News
    7.15 Creative Biogene
        7.15.1 Creative Biogene Corporate Summary
        7.15.2 Creative Biogene Business Overview
        7.15.3 Creative Biogene Oligonucleotides Major Product Offerings
        7.15.4 Creative Biogene Oligonucleotides Revenue in Global (2016-2021)
        7.15.5 Creative Biogene Key News
    7.16 General Biosystems
        7.16.1 General Biosystems Corporate Summary
        7.16.2 General Biosystems Business Overview
        7.16.3 General Biosystems Oligonucleotides Major Product Offerings
        7.16.4 General Biosystems Oligonucleotides Revenue in Global (2016-2021)
        7.16.5 General Biosystems Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com